| __timestamp | Amphastar Pharmaceuticals, Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 9335772 |
| Thursday, January 1, 2015 | 46974000 | 12390000 |
| Friday, January 1, 2016 | 47298000 | 25602000 |
| Sunday, January 1, 2017 | 50918000 | 21262000 |
| Monday, January 1, 2018 | 58044000 | 28430000 |
| Tuesday, January 1, 2019 | 63109000 | 40849000 |
| Wednesday, January 1, 2020 | 65157000 | 60210000 |
| Friday, January 1, 2021 | 68920000 | 83664000 |
| Saturday, January 1, 2022 | 66592000 | 104097000 |
| Sunday, January 1, 2023 | 80393000 | 106916000 |
Infusing magic into the data realm
In the competitive landscape of biopharmaceuticals, effective cost management is crucial. Over the past decade, Amphastar Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc. have demonstrated distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Amphastar's SG&A expenses grew by approximately 99%, reflecting a strategic expansion in operations. Meanwhile, Iovance's expenses surged by over 1,000%, indicating aggressive investment in growth and development.
These trends underscore the diverse strategies employed by biopharma companies in managing operational costs while pursuing innovation and market expansion.
Cost Management Insights: SG&A Expenses for argenx SE and Iovance Biotherapeutics, Inc.
Selling, General, and Administrative Costs: argenx SE vs Amphastar Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Biogen Inc. and Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Amphastar Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Grifols, S.A. or Iovance Biotherapeutics, Inc.
Verona Pharma plc vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Bausch Health Companies Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
SG&A Efficiency Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc.